TERM ID="NYU_TERM_1" STRING="BCC" FREQUENCY=2 START=175 END=178 LEMMA="BASAL CELL CARCINOMA" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_2" STRING="BCC" FREQUENCY=2 START=484 END=487 LEMMA="BASAL CELL CARCINOMA" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_3" STRING="C-KIT" FREQUENCY=1 START=2292 END=2297 LEMMA="C-KIT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="Comparative study" FREQUENCY=1 START=1173 END=1190 LEMMA="COMPARATIVE STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="Concerning melanoma" FREQUENCY=1 START=1036 END=1055 LEMMA="CONCERNING MELANOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="DTIC" FREQUENCY=5 START=1213 END=1217 LEMMA="DTIC" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_7" STRING="DTIC" FREQUENCY=5 START=1286 END=1290 LEMMA="DTIC" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_8" STRING="DTIC" FREQUENCY=5 START=1418 END=1422 LEMMA="DTIC" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_9" STRING="DTIC" FREQUENCY=5 START=1697 END=1701 LEMMA="DTIC" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_10" STRING="DTIC" FREQUENCY=5 START=1728 END=1732 LEMMA="DTIC" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_11" STRING="EBDR skin cancers" FREQUENCY=1 START=642 END=659 LEMMA="EBDR SKIN CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="Ferguson Smith syndrome" FREQUENCY=1 START=804 END=827 LEMMA="FERGUSON SMITH SYNDROME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="HPV" FREQUENCY=1 START=635 END=638 LEMMA="HUMAN PAPILLOMAVIRUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="Laboratory work" FREQUENCY=1 START=452 END=467 LEMMA="LABORATORY WORK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="MAPK" FREQUENCY=1 START=2129 END=2133 LEMMA="MAPK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="Merkel carcinoma" FREQUENCY=1 START=2607 END=2623 LEMMA="MERKEL CARCINOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="PEG-interferon" FREQUENCY=1 START=2162 END=2176 LEMMA="PEG-INTERFERON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="PEP005" FREQUENCY=1 START=944 END=950 LEMMA="PEP005" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="Photodynamic therapy induced-immunosuppression" FREQUENCY=1 START=680 END=726 LEMMA="PHOTODYNAMIC THERAPY INDUCED-IMMUNOSUPPRESSION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_20" STRING="Recommendations" FREQUENCY=1 START=2547 END=2562 LEMMA="RECOMMENDATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="SCC" FREQUENCY=3 START=223 END=226 LEMMA="SQUAMOUS CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_22" STRING="SCC" FREQUENCY=3 START=900 END=903 LEMMA="SQUAMOUS CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_23" STRING="SCC" FREQUENCY=3 START=2093 END=2096 LEMMA="SQUAMOUS CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_24" STRING="SCC stem cells" FREQUENCY=1 START=492 END=506 LEMMA="SCC STEM CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="Sarcoma" FREQUENCY=1 START=2810 END=2817 LEMMA="SARCOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_26" STRING="T cell cutaneous lymphomas" FREQUENCY=1 START=3161 END=3187 LEMMA="T CELL CUTANEOUS LYMPHOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="actinic keratosis" FREQUENCY=1 START=1017 END=1034 LEMMA="ACTINIC KERATOSI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="activation" FREQUENCY=1 START=2115 END=2125 LEMMA="ACTIVATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="activation of MAPK" FREQUENCY=1 START=2115 END=2133 LEMMA="MAPK ACTIVATION" LEMMA_FREQUENCY=1 HEAD_TERM="activation" HEAD_LEMMA="ACTIVATION"
TERM ID="NYU_TERM_30" STRING="anti-Braf" FREQUENCY=2 START=1126 END=1135 LEMMA="ANTI-BRAF" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_31" STRING="anti-Braf" FREQUENCY=2 START=1199 END=1208 LEMMA="ANTI-BRAF" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_32" STRING="anti-Braf drugs" FREQUENCY=1 START=2064 END=2079 LEMMA="ANTI-BRAF DRUG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="anti-EGFR" FREQUENCY=1 START=184 END=193 LEMMA="ANTI-EGFR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="anti-EGFR for squamous cell carcinoma" FREQUENCY=1 START=184 END=221 LEMMA="SQUAMOUS CELL CARCINOMA ANTI-EGFR" LEMMA_FREQUENCY=1 HEAD_TERM="anti-EGFR" HEAD_LEMMA="ANTI-EGFR"
TERM ID="NYU_TERM_35" STRING="anti-MEK" FREQUENCY=1 START=2302 END=2310 LEMMA="ANTI-MEK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="anti-patch/sonic/hedgehog" FREQUENCY=1 START=123 END=148 LEMMA="ANTI-PATCH/SONIC/HEDGEHOG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="anti-patch/sonic/hedgehog for basal cell carcinoma" FREQUENCY=1 START=123 END=173 LEMMA="BASAL CELL CARCINOMA ANTI-PATCH/SONIC/HEDGEHOG" LEMMA_FREQUENCY=1 HEAD_TERM="anti-patch/sonic/hedgehog" HEAD_LEMMA="ANTI-PATCH/SONIC/HEDGEHOG"
TERM ID="NYU_TERM_38" STRING="anti-tumoral efficacy" FREQUENCY=1 START=311 END=332 LEMMA="ANTI-TUMORAL EFFICACY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="basal cell carcinoma" FREQUENCY=2 START=153 END=173 LEMMA="BASAL CELL CARCINOMA" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_40" STRING="basal cell carcinoma" FREQUENCY=2 START=153 END=173 LEMMA="BASAL CELL CARCINOMA" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_41" STRING="collaborative work" FREQUENCY=1 START=2963 END=2981 LEMMA="COLLABORATIVE WORK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="combination ipilimumab" FREQUENCY=1 START=1673 END=1695 LEMMA="COMBINATION IPILIMUMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="compound" FREQUENCY=1 START=934 END=942 LEMMA="COMPOUND" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="concerning skin carcinoma" FREQUENCY=1 START=57 END=82 LEMMA="CONCERNING SKIN CARCINOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="cutaneous lymphomas" FREQUENCY=1 START=3244 END=3263 LEMMA="CUTANEOUS LYMPHOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="dermato-oncology" FREQUENCY=1 START=14 END=30 LEMMA="DERMATO-ONCOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="developping anti-Braf" FREQUENCY=1 START=1936 END=1957 LEMMA="DEVELOPPING ANTI-BRAF" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="diagnostic tools" FREQUENCY=1 START=3128 END=3144 LEMMA="DIAGNOSTIC TOOL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="encoding TGFBR1" FREQUENCY=1 START=864 END=879 LEMMA="ENCODING TGFBR1" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="fluence" FREQUENCY=1 START=766 END=773 LEMMA="FLUENCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="imatinib" FREQUENCY=1 START=2874 END=2882 LEMMA="IMATINIB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="ingenol mebutate" FREQUENCY=1 START=953 END=969 LEMMA="INGENOL MEBUTATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_53" STRING="innovative therapies" FREQUENCY=1 START=1104 END=1124 LEMMA="INNOVATIVE THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_54" STRING="ipilimumab" FREQUENCY=1 START=1140 END=1150 LEMMA="IPILIMUMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_55" STRING="lymph node micrometastasis" FREQUENCY=1 START=2226 END=2252 LEMMA="LYMPH NODE MICROMETASTASI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="mTOR inhibitors" FREQUENCY=1 START=2912 END=2927 LEMMA="MTOR INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="melanoma" FREQUENCY=2 START=2212 END=2220 LEMMA="MELANOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_58" STRING="melanoma" FREQUENCY=2 START=2491 END=2499 LEMMA="MELANOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_59" STRING="melanoma risk prevention" FREQUENCY=1 START=2361 END=2385 LEMMA="MELANOMA RISK PREVENTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="microRNA" FREQUENCY=1 START=3104 END=3112 LEMMA="MICRORNA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_61" STRING="molecular events" FREQUENCY=1 START=565 END=581 LEMMA="MOLECULAR EVENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_62" STRING="non" FREQUENCY=1 START=272 END=275 LEMMA="NON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_63" STRING="non Braf" FREQUENCY=1 START=2137 END=2145 LEMMA="NON BRAF" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_64" STRING="positive sentinel lymph nodes" FREQUENCY=1 START=2666 END=2695 LEMMA="POSITIVE SENTINEL LYMPH NODE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_65" STRING="prescribers" FREQUENCY=1 START=1863 END=1874 LEMMA="PRESCRIBER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_66" STRING="response rate" FREQUENCY=1 START=1230 END=1243 LEMMA="RESPONSE RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_67" STRING="sarcomas" FREQUENCY=1 START=2951 END=2959 LEMMA="SARCOMA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_68" STRING="squamous cell carcinoma" FREQUENCY=2 START=198 END=221 LEMMA="SQUAMOUS CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_69" STRING="squamous cell carcinoma" FREQUENCY=2 START=198 END=221 LEMMA="SQUAMOUS CELL CARCINOMA" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_70" STRING="subgroup" FREQUENCY=1 START=2741 END=2749 LEMMA="SUBGROUP" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_71" STRING="sunscreens" FREQUENCY=1 START=2347 END=2357 LEMMA="SUNSCREEN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_72" STRING="suspensive" FREQUENCY=1 START=374 END=384 LEMMA="SUSPENSIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_73" STRING="term use" FREQUENCY=1 START=442 END=450 LEMMA="TERM USE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_74" STRING="therapeutic strategies" FREQUENCY=1 START=1984 END=2006 LEMMA="THERAPEUTIC STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_75" STRING="therapeutical options" FREQUENCY=1 START=991 END=1012 LEMMA="THERAPEUTICAL OPTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_76" STRING="therapeutical options for actinic keratosis" FREQUENCY=1 START=991 END=1034 LEMMA="ACTINIC KERATOSI THERAPEUTICAL OPTION" LEMMA_FREQUENCY=1 HEAD_TERM="therapeutical options" HEAD_LEMMA="THERAPEUTICAL OPTION"
TERM ID="NYU_TERM_77" STRING="therapeutical strategies" FREQUENCY=1 START=3216 END=3240 LEMMA="THERAPEUTICAL STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_78" STRING="tolerability" FREQUENCY=1 START=420 END=432 LEMMA="TOLERABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_79" STRING="vemurafenib" FREQUENCY=1 START=1259 END=1270 LEMMA="VEMURAFENIB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_80" STRING="way cutaneous T lymphomas" FREQUENCY=1 START=3042 END=3067 LEMMA="WAY CUTANEOUS T LYMPHOMA" LEMMA_FREQUENCY=1
